Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04099823 · ClinicalTrials.gov registry record · NA
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
A NA study of Alzheimer Disease and Hydrocephalus, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04099823: Recruiting NA study of Alzheimer Disease and Hydrocephalus, sponsored by Mayo Clinic.
NCT04099823 is a NA study of Alzheimer Disease and Hydrocephalus that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04099823, a NA study of Alzheimer Disease and Hydrocephalus, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The Researchers are trying to test a MR imaging method for detection of Cerebral Spinal Fluid (CSF) flow in the brain to help diagnosis and better understand diseases that affect brain function.
Primary Outcome
CSF flow will be measured in participants and compared between those with unimpaired brain function and those with clinical diagnosis of a disease that affects brain function, such as Alzheimer's disease and normal pressure hydrocephalus.
Conditions Studied
Interventions
- OTHER MRI screening form
- DIAGNOSTIC_TEST Urine pregnancy test
- DIAGNOSTIC_TEST MR brain
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-10-31 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT04099823 shows while recruiting
NCT04099823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 3 interventions - of which MRI screening form is the first listed.
NCT04099823 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04099823 about?
NCT04099823 is a clinical study titled "MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics". The Researchers are trying to test a MR imaging method for detection of Cerebral Spinal Fluid (CSF) flow in the brain to help diagnosis and better understand diseases that affect brain function.
What is the current status of trial NCT04099823?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2019-10-31. Estimated completion is 2027-01.
What conditions does trial NCT04099823 study?
This clinical trial studies the following conditions: Alzheimer Disease, Hydrocephalus.
What interventions are being tested in trial NCT04099823?
The interventions under investigation include: MRI screening form (OTHER), Urine pregnancy test (DIAGNOSTIC_TEST), MR brain (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04099823?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04099823 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04099823's enrollment target sits among peer trials
50 210th of 306 higher than 93 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI